Literature DB >> 33649955

Determination of Bile Salt Hydrolase Activity in Bifidobacteria.

Lorena Ruiz1,2, Borja Sánchez3,4, Abelardo Margolles3,4.   

Abstract

Bile salt hydrolase (BSH) activity is a desirable trait in putative probiotic bacteria, such as those belonging to the Bifidobacterium genus. On the one hand, bile salt hydrolysis is considered to represent a bile detoxification mechanism for gut commensal bacteria and thus the presence of this activity was believed to be a predictor of bile tolerance of putative probiotic strains. On the other hand, it has recently been revealed that chemical modifications of the bile acid pool performed by the gut microbiota strongly impact on host health. This explains the increasing interest to investigate the role played by bile-modifying enzymes of gut commensals on lowering cholesterol levels, on modulating gut inflammation or on influencing the development of cancer or metabolic disorders. This chapter compiles qualitative and quantitative methods to analyse BSH activity in bifidobacteria, though they could be adapted to other bacterial groups of interest.

Entities:  

Keywords:  Bifidobacteria; Bile salt hydrolase

Mesh:

Substances:

Year:  2021        PMID: 33649955     DOI: 10.1007/978-1-0716-1274-3_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

Review 1.  Probiotic bile salt hydrolase: current developments and perspectives.

Authors:  Anil K Patel; Reeta R Singhania; Ashok Pandey; Sudhir B Chincholkar
Journal:  Appl Biochem Biotechnol       Date:  2009-08-11       Impact factor: 2.926

Review 2.  Bile salt biotransformations by human intestinal bacteria.

Authors:  Jason M Ridlon; Dae-Joong Kang; Phillip B Hylemon
Journal:  J Lipid Res       Date:  2005-11-18       Impact factor: 5.922

Review 3.  In Sickness and in Health: The Relationships Between Bacteria and Bile in the Human Gut.

Authors:  A J Hay; J Zhu
Journal:  Adv Appl Microbiol       Date:  2016-08-05       Impact factor: 5.086

Review 4.  Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications.

Authors:  Mitchell L Jones; Catherine Tomaro-Duchesneau; Christopher J Martoni; Satya Prakash
Journal:  Expert Opin Biol Ther       Date:  2013-01-28       Impact factor: 4.388

5.  Genetic analysis of a bile salt hydrolase in Bifidobacterium animalis subsp. lactis KL612.

Authors:  G-B Kim; B H Lee
Journal:  J Appl Microbiol       Date:  2008-04-25       Impact factor: 3.772

6.  Relationship between bile salt hydrolase activity, changes in the internal pH and tolerance to bile acids in lactic acid bacteria.

Authors:  Ana Yanina Bustos; Lucila Saavedra; Graciela Font de Valdez; Raúl Ricardo Raya; María Pía Taranto
Journal:  Biotechnol Lett       Date:  2012-04-18       Impact factor: 2.461

7.  Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract.

Authors:  Matthew H Foley; Sarah O'Flaherty; Rodolphe Barrangou; Casey M Theriot
Journal:  PLoS Pathog       Date:  2019-03-07       Impact factor: 6.823

8.  Genetic diversity of bile salt hydrolases among human intestinal bifidobacteria.

Authors:  Piotr Jarocki; Zdzisław Targoński
Journal:  Curr Microbiol       Date:  2013-04-17       Impact factor: 2.188

  8 in total
  2 in total

1.  Lactic Acid Bacteria Isolated from Fresh Vegetable Products: Potential Probiotic and Postbiotic Characteristics Including Immunomodulatory Effects.

Authors:  Fatima Alameri; Mohammad Tarique; Tareq Osaili; Riyad Obaid; Abdelmoneim Abdalla; Razan Masad; Ashraf Al-Sbiei; Maria Fernandez-Cabezudo; Shao-Quan Liu; Basel Al-Ramadi; Mutamed Ayyash
Journal:  Microorganisms       Date:  2022-02-08

2.  Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism.

Authors:  Fangfei Xiao; Fang Dong; Xiaolu Li; Youran Li; Guangjun Yu; Zhanju Liu; Yizhong Wang; Ting Zhang
Journal:  Front Pharmacol       Date:  2022-08-01       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.